AstraZeneca Pharma India Fined ₹1.88 Lakhs for Delayed Filing

AstraZeneca Pharma India Ltd has been penalized ₹1,88,000 by the Registrar of Companies (ROC) for a delay in filing Form MR-2 concerning the appointment of Dr. Sanjeev Kumar Panchal as Managing Director. The company and its erstwhile officers also face penalties of ₹50,000 each. The delay was attributed to technical glitches on the Ministry of Corporate Affairs portal, which erroneously marked Dr. Panchal's DIN as inactive. The ROC order was received on September 17, 2026. The company has explained the situation and provided details as required by SEBI regulations.